ARTICLE | Company News
Activated Cell Therapy Inc., Immune Response deal
July 7, 1997 7:00 AM UTC
Activated Cell Therapy acquired an exclusive worldwide license from IMNR to a European patent covering the use of antigen-presenting dendritic cells as cell therapies against B-cell lymphoma. The pate...